All News

Officials with the FDA have granted GBC0905, for the treatment of facioscapulohumeral muscular dystrophy (FSHD), an Orphan Drug Designation.

At the American Pharmacy Purchasing Alliance’s PharmCon in Orlando, FL, experts with collaborative practice experience discussed why these pharmacist-physician partnerships are useful, and how they can effectively work.

Individuals who inject drugs are at an increased risk of developing invasive methicillin-resistant Staphylococcus aureus (MRSA).

During a presentation at the American Pharmacy Purchasing Alliance's Pharmacon in Orlando, FL, several panelists discussed the use of nutraceuticals in managing conditions like chronic pain.

Change is needed to create a better working relationship between pharmacy benefit managers (PBMs) and independent pharmacies, according to a panel of experts at the American Pharmacy Purchasing Alliance (APPA) conference in Orlando, FL.

The deaths this week of Kate Spade and Anthony Bourdain have sparked a much-needed public discussion about mental health and suicide can be prevented.

As one of the most accessible health care providers, our patients come to us seeking advice not only for prescription medication and OTC questions but also on the big question: "How do I get healthy?"

An esteemed panel will deliberate more than 600 nominations.

Patients with both private and public insurers face high denial rates across the United States for life-saving hepatitis C drugs, despite changes in restrictions and increased price competition.

Top news of the week from Specialty Pharmacy Times.

Top news of the week from The American Journal of Pharmacy Benefits.

Top news of the day from across the health care landscape

The therapy has been approved to treat pemphigus vulgaris (PV), a condition characterized by progressive blistering of the skin and mucous membranes

With the approval, rituximab has become the first biologic therapy approved by the FDA for PV, and the first major advancement in treatment of the condition in 6 decades.

A new report from the US Centers for Disease Control and Prevention (CDC) has shown that suicide rates are rising in nearly every state.

Half of people who have diabetes eventually develop diabetic peripheral neuropathy, and the warning signs are sensory symptoms that start in the distant periphery and progressing in a characteristic 'glove and stocking' way.

Delayed or failed degree completion is associated with much higher economic consequences for advanced-degree as compared to baccalaureate-degree programs.

Indazole chloride may be able to reduce disability burden in patients with multiple sclerosis by producing good inflammation that promotes axon myelination.

Top news of the day from across the health care landscape

A systematic literature review published in Health Affairs found that Medicaid expansion under the Affordable Care Act (ACA) was associated with increases in coverage, service use, quality of care, and Medicaid spending.

Among HIV-positive women with diabetes, HIV control has improved over time, but diabetes control has not.

An evaluation of the impact of persistence to oral antidiabetic medication on reducing the risk of hospitalization in adult patients with type 2 diabetes.

Point-of-care testing (POTC) increase patients' access to care and treatment. In 2 areas—influenza and streptococcal pharyngitis—POCT is available, but not used as often as it could be.

Kidney disease occurs along a continuum, and for people who have diabetes, the risk of developing kidney disease is significantly elevated.

Should emergency room clinicians use a breath-actuated nebulizer (BAN) or is a metered-dose inhaler (MDI) a better choice?

Although precision medicine holds promise for advanced cancer care, many oncologists indicated challenges in the adoption of new, targeted therapies.

Top news of the day from across the health care landscape.